The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

TBPH FINANCIAL STATEMENTS

Theravance Biopharma Inc — balance sheet, income statement and cash flow trends

TBPHTheravance Biopharma Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
0500 M20202021202420252026

Profit Funnel

Q2 2026 · TTM
Revenue104.3 M $Gross Profit93.3 M $ · 89%Operating Income4.7 M $ · 4%Pre-tax Income58.9 M $ · 56%Net Income to Owners53.8 M $ · 52%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue104.3 M $+35.1%
Gross Profit93.3 M $+155.2%
Operating Income4.7 M $—
EBITDA68.5 M $+53.0%
Net Income to Owners53.8 M $+312.9%

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
0500 M20202021202420252026

Capital Structure

Q2 2026
Total Assets469.8 M
  • Equity289.7 M $62%
  • Current Liabilities30.8 M $7%
  • Long-term Liabilities149.3 M $32%

Key Figures

YoY change
Total Assets469.8 M $+10.3%
Total Liabilities180.1 M $-10.5%
Total Equity289.7 M $+28.8%
Cash & ST Investments387.7 M $+14.4%
Total Debt38.6 M $-17.0%
Net Debt-181.2 M $—

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-200 M0200 M20202021202420252026

Cash Flow Bridge

Q2 2026 · TTM
-50 M050 M51.8 M $Operating-107.5 M $Investing-2.9 M $Financing-58.5 M $Net Change

Key Figures

YoY change
Operating Cash Flow51.8 M $-78.8%
Capital Expenditures8 K $-96.7%
Free Cash Flow51.8 M $-78.8%
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on TBPH

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 11, 26. This content is for informational purposes only and is not investment advice.